We previously reported that a functional variant (LTA C+80A) in lymphotoxin alpha, a proinflammatory cytokine, modified the protective effect of NSAIDs on prostate cancer (Liu et al, 2006). The gene discussed is LTA; the disease is prostate carcinoma.